Misonix Stock Price, News & Analysis (NASDAQ:MSON)

$9.65 0.00 (0.00 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$9.65
Today's Range$9.49 - $9.90
52-Week Range$7.05 - $12.00
Volume10,456 shs
Average Volume7,856 shs
Market Capitalization$90.38 million
P/E RatioN/A
Dividend YieldN/A
Beta0.19

About Misonix (NASDAQ:MSON)

Misonix, Inc. designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company's products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the neurosurgery, orthopedic surgery, plastic surgery, wounds, burn and maxillo-facial clinical specialties. The BoneScalpel is an ultrasonic cutting system that makes cuts with minimal necrosis, minimal burn artifact, minimal inflammation and minimal bone loss. The SonaStar system provides precise aspiration following the ultrasonic ablation of hard or soft tissue. The SonicOne Ultrasonic Cleansing and Debridement System is a tissue specific approach for the removal of devitalized or necrotic tissue and fibrin deposits while sparing viable, surrounding cellular structures.

Receive MSON News and Ratings via Email

Sign-up to receive the latest news and ratings for MSON and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:MSON
CUSIPN/A
Phone+1-631-6949555

Debt

Debt-to-Equity RatioN/A
Current Ratio5.20%
Quick Ratio3.87%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$27.27 million
Price / Sales3.32
Cash FlowN/A
Price / CashN/A
Book Value$3.12 per share
Price / Book3.09

Profitability

Trailing EPS($0.29)
Net Income$-1,680,000.00
Net Margins-8.40%
Return on Equity-9.08%
Return on Assets-7.92%

Miscellaneous

Employees92
Outstanding Shares9,370,000

Misonix (NASDAQ:MSON) Frequently Asked Questions

What is Misonix's stock symbol?

Misonix trades on the NASDAQ under the ticker symbol "MSON."

How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) released its quarterly earnings results on Monday, March, 13th. The medical equipment provider reported ($0.07) EPS for the quarter. The medical equipment provider had revenue of $6.03 million for the quarter. Misonix had a negative return on equity of 9.08% and a negative net margin of 8.40%. View Misonix's Earnings History.

Who are some of Misonix's key competitors?

Who are Misonix's key executives?

Misonix's management team includes the folowing people:

  • Stavros G. Vizirgianakis, President, Chief Executive Officer, Director (Age 45)
  • Joseph P. Dwyer, Chief Financial Officer, Treasurer, Secretary (Age 61)
  • Robert Scott Ludecker, Senior Vice President - Global Sales and Marketing (Age 48)
  • Joseph J. Brennan, Vice President - Operations (Age 51)
  • Chris Wright, Vice President - US Sales
  • John J. Salerno, Vice President - Quality and Regulatory Affairs (Age 60)
  • Daniel Voic, Vice President - Research & Development and Engineering (Age 53)
  • John W. Gildea, Independent Director (Age 73)
  • Patrick A. McBrayer, Independent Director (Age 63)
  • Charles Miner III, Independent Director (Age 64)

Who owns Misonix stock?

Misonix's stock is owned by a number of of retail and institutional investors. Top institutional investors include SOUTH AFRICA ALPHA CAPITAL MANAGEMENT LTD. (5.10%), Dimensional Fund Advisors LP (4.65%), WealthTrust Axiom LLC (0.75%) and Rathbone Brothers plc (0.16%). Company insiders that own Misonix stock include Joseph P Dwyer, Michael A Mcmanus Jr and Stavros G Vizirgianakis. View Institutional Ownership Trends for Misonix.

Who sold Misonix stock? Who is selling Misonix stock?

Misonix's stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, WealthTrust Axiom LLC and Rathbone Brothers plc. View Insider Buying and Selling for Misonix.

How do I buy Misonix stock?

Shares of Misonix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Misonix's stock price today?

One share of Misonix stock can currently be purchased for approximately $9.65.

How big of a company is Misonix?

Misonix has a market capitalization of $90.38 million and generates $27.27 million in revenue each year. The medical equipment provider earns $-1,680,000.00 in net income (profit) each year or ($0.29) on an earnings per share basis. Misonix employs 92 workers across the globe.

How can I contact Misonix?

Misonix's mailing address is 1938 New Hwy, FARMINGDALE, NY 11735-1204, United States. The medical equipment provider can be reached via phone at +1-631-6949555.


MarketBeat Community Rating for Misonix (MSON)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  35 (Vote Underperform)
Total Votes:  65
MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Misonix (NASDAQ:MSON) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Misonix (NASDAQ:MSON) Earnings History and Estimates Chart

Earnings by Quarter for Misonix (NASDAQ:MSON)

Misonix (NASDAQ MSON) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2017Q3 2017($0.04)$7.18 millionViewListenView Earnings Details
3/13/2017Q1 2017($0.07)$6.03 millionViewN/AView Earnings Details
2/9/2016Q216$0.02$5.60 million$6.00 millionViewListenView Earnings Details
11/5/2015Q116($0.03)$4.50 million$5.30 millionViewListenView Earnings Details
8/20/2015Q415$0.46$5.60 million$6.70 millionViewListenView Earnings Details
5/7/2015Q315$0.06$0.05$4.30 million$5.30 millionViewListenView Earnings Details
2/4/2015Q215$0.07$0.11$4.10 million$5.60 millionViewListenView Earnings Details
9/10/2014Q4$0.02$0.18$5.60 millionViewListenView Earnings Details
2/5/2014Q2$0.06ViewListenView Earnings Details
9/24/2013Q413($0.22)$5.30 million$3.80 millionViewListenView Earnings Details
11/7/2012Q113$0.01$3.20 million$4.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Misonix (NASDAQ:MSON) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Misonix (NASDAQ:MSON)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Misonix (NASDAQ MSON) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 24.60%
Institutional Ownership Percentage: 10.37%
Insider Trades by Quarter for Misonix (NASDAQ:MSON)
Insider Trades by Quarter for Misonix (NASDAQ:MSON)

Misonix (NASDAQ MSON) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2017Joseph P DwyerCFOBuy500$10.60$5,300.00View SEC Filing  
10/25/2016Stavros G VizirgianakisCEOBuy761,469$5.25$3,997,712.25View SEC Filing  
6/30/2016Michael A Mcmanus JrCEOBuy20,000$1.91$38,200.00View SEC Filing  
9/16/2015Richard A. ZarembaCFOSell10,000$10.42$104,200.00View SEC Filing  
9/11/2015Charles MinerDirectorSell15,000$10.20$153,000.00View SEC Filing  
9/4/2015Richard A. ZarembaCFOSell2,031$11.10$22,544.10View SEC Filing  
9/2/2015Richard A. ZarembaCFOSell1,555$11.13$17,307.15View SEC Filing  
6/16/2015Howard AlligerDirectorSell1,000$10.91$10,910.00View SEC Filing  
2/25/2015Thomas F OneillDirectorSell5,000$11.18$55,900.00View SEC Filing  
2/23/2015Ronald MannaVPSell17,600$11.28$198,528.00View SEC Filing  
2/20/2015Thomas F OneillDirectorSell3,700$12.43$45,991.00View SEC Filing  
2/18/2015Michael A Mcmanus JrCEOSell12,619$12.64$159,504.16View SEC Filing  
2/17/2015Howard AlligerDirectorBuy15,000$5.87$88,050.00View SEC Filing  
2/13/2015John GildeaDirectorBuy15,000$5.87$88,050.00View SEC Filing  
2/12/2015Richard A ZarembaCFOSell8,775$13.06$114,601.50View SEC Filing  
2/12/2015T Guy MinettiDirectorBuy15,000$5.87$88,050.00View SEC Filing  
2/11/2015Thomas F OneillDirectorBuy15,000$5.87$88,050.00View SEC Filing  
2/10/2015Howard AlligerDirectorSell2,400$13.42$32,208.00View SEC Filing  
2/10/2015Richard A ZarembaCFOSell7,449$13.62$101,455.38View SEC Filing  
2/9/2015Howard AlligerDirectorSell9,600$13.88$133,248.00View SEC Filing  
11/20/2014Richard A ZarembaCFOSell9,289$11.69$108,588.41View SEC Filing  
11/13/2014Howard AlligerDirectorSell3,000$12.11$36,330.00View SEC Filing  
11/13/2014Michael A Mcmanus JrCEOSell10,630$12.05$128,091.50View SEC Filing  
11/12/2014Charles MinerDirectorBuy2,500$12.00$30,000.00View SEC Filing  
11/12/2014Richard A ZarembaCFOSell1,211$12.72$15,403.92View SEC Filing  
9/15/2014Howard AlligerDirectorSell15,000$8.95$134,250.00View SEC Filing  
6/16/2014Stavros G VizirgianakisDirectorBuy69,509$5.70$396,201.30View SEC Filing  
6/13/2014Robert S LudeckerVPBuy2,943$5.90$17,363.70View SEC Filing  
5/12/2014Michael A Mcmanus JrCEOBuy25,000$1.82$45,500.00View SEC Filing  
3/6/2014Howard AlligerDirectorSell7,500$6.86$51,450.00View SEC Filing  
2/20/2014Michael A Mcmanus JrCEOBuy25,000$1.91$47,750.00View SEC Filing  
1/16/2014T Guy MinettiDirectorBuy15,000$4.99$74,850.00View SEC Filing  
1/13/2014Thomas F OneillDirectorBuy22,500$2.58$58,050.00View SEC Filing  
10/21/2013Richard A ZarembaCFOBuy7,500$1.82$13,650.00View SEC Filing  
5/13/2013Richard A ZarembaCFOBuy15,000$2.04$30,600.00View SEC Filing  
3/6/2013Thomas F OneillDirectorBuy15,000$3.21$48,150.00View SEC Filing  
3/4/2013T Guy MinettiDirectorBuy15,000$3.21$48,150.00View SEC Filing  
2/12/2013Michael A Mcmanus JrCEOBuy10,000$4.66$46,600.00View SEC Filing  
2/12/2013Richard A ZarembaCFOBuy1,250$0.85$1,062.50View SEC Filing  
11/26/2012Howard AlligerDirectorSell20,000$4.10$82,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Misonix (NASDAQ MSON) News Headlines

Source:
DateHeadline
ETFs with exposure to Misonix, Inc. : November 9, 2017ETFs with exposure to Misonix, Inc. : November 9, 2017
finance.yahoo.com - November 12 at 8:48 AM
Misonix Reports First Quarter Fiscal Year 2018 Financial ResultsMisonix Reports First Quarter Fiscal Year 2018 Financial Results
finance.yahoo.com - November 9 at 6:01 AM
Edited Transcript of MSON earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of MSON earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 9 at 6:01 AM
MISONIX, Inc. (MSON) to Release Earnings on TuesdayMISONIX, Inc. (MSON) to Release Earnings on Tuesday
www.americanbankingnews.com - October 31 at 1:16 PM
Misonix Cites Significant Healthcare Cost Savings Using BoneScalpel in Bone Removal ProceduresMisonix Cites Significant Healthcare Cost Savings Using BoneScalpel in Bone Removal Procedures
finance.yahoo.com - October 27 at 8:08 AM
Misonix Enters into $11 Million License, Royalty and Manufacturing AgreementMisonix Enters into $11 Million License, Royalty and Manufacturing Agreement
finance.yahoo.com - October 21 at 6:43 AM
Misonix, Inc. to Report First Quarter Fiscal Year 2018 Financial Results on Tuesday, November 7, 2017Misonix, Inc. to Report First Quarter Fiscal Year 2018 Financial Results on Tuesday, November 7, 2017
finance.yahoo.com - October 18 at 7:15 AM
Misonix, Inc. :MSON-US: Earnings Analysis: Q4, 2017 By the Numbers : September 29, 2017Misonix, Inc. :MSON-US: Earnings Analysis: Q4, 2017 By the Numbers : September 29, 2017
finance.yahoo.com - October 2 at 5:37 PM
ETFs with exposure to Misonix, Inc. : October 2, 2017ETFs with exposure to Misonix, Inc. : October 2, 2017
finance.yahoo.com - October 2 at 5:37 PM
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of the Securities of Misonix, Inc. – MSONThe Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of the Securities of Misonix, Inc. – MSON
finance.yahoo.com - September 19 at 12:01 AM
Corporate News Blog - Medtronic Voluntarily Recalls Diabetes Infusion Sets WorldwideCorporate News Blog - Medtronic Voluntarily Recalls Diabetes Infusion Sets Worldwide
finance.yahoo.com - September 14 at 7:59 AM
ETFs with exposure to Misonix, Inc. : August 31, 2017ETFs with exposure to Misonix, Inc. : August 31, 2017
finance.yahoo.com - September 1 at 6:07 AM
Misonix, Inc. :MSON-US: Earnings Analysis: 2017 By the Numbers : August 28, 2017Misonix, Inc. :MSON-US: Earnings Analysis: 2017 By the Numbers : August 28, 2017
finance.yahoo.com - August 29 at 2:57 AM
MISONIXs (MSON) CEO Stavros Vizirgianakis on Q4 2017 Results - Earnings Call TranscriptMISONIX's (MSON) CEO Stavros Vizirgianakis on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - August 23 at 8:44 AM
Edited Transcript of MSON earnings conference call or presentation 22-Aug-17 8:30pm GMTEdited Transcript of MSON earnings conference call or presentation 22-Aug-17 8:30pm GMT
finance.yahoo.com - August 23 at 8:44 AM
Misonix Reports Fiscal Year 2017 Financial ResultsMisonix Reports Fiscal Year 2017 Financial Results
finance.yahoo.com - August 22 at 4:23 PM
MISONIX, Inc. (NASDAQ:MSON) Set to Announce Earnings on ThursdayMISONIX, Inc. (NASDAQ:MSON) Set to Announce Earnings on Thursday
www.americanbankingnews.com - August 10 at 7:32 AM
Misonix, Inc. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, August 22, 2017Misonix, Inc. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, August 22, 2017
finance.yahoo.com - August 4 at 5:38 AM
ETFs with exposure to Misonix, Inc. : July 12, 2017ETFs with exposure to Misonix, Inc. : July 12, 2017
finance.yahoo.com - July 13 at 7:02 AM
MISONIXs (MSON) CEO Stavros Vizirgianakis on Q3 2017 Results - Earnings Call TranscriptMISONIX's (MSON) CEO Stavros Vizirgianakis on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - May 3 at 11:40 PM
Misonix reports 3Q lossMisonix reports 3Q loss
marketbeat.com - May 2 at 6:13 PM
Misonix, Inc. :MSON-US: Earnings Analysis: Q2, 2017 By the Numbers : March 17, 2017Misonix, Inc. :MSON-US: Earnings Analysis: Q2, 2017 By the Numbers : March 17, 2017
us.rd.yahoo.com - March 19 at 9:53 AM
Misonixs (MSON) CEO Stavros Vizirgianakis on Q4 2016 Results - Earnings Call TranscriptMisonix's (MSON) CEO Stavros Vizirgianakis on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 16 at 9:08 AM
Misonix Inc Earnings Call scheduled for 9:00 am ET todayMisonix Inc Earnings Call scheduled for 9:00 am ET today
biz.yahoo.com - March 14 at 11:00 AM
Q1 2017 Misonix Inc Earnings Release - Before Market OpenQ1 2017 Misonix Inc Earnings Release - Before Market Open
biz.yahoo.com - March 14 at 11:00 AM
MISONIX INC Files SEC form 10-Q, Quarterly ReportMISONIX INC Files SEC form 10-Q, Quarterly Report
us.rd.yahoo.com - March 13 at 6:22 PM
Misonix Files Forms 10-Q for First and Second Quarters of Fiscal 2017Misonix Files Forms 10-Q for First and Second Quarters of Fiscal 2017
us.rd.yahoo.com - March 13 at 6:22 PM
Misonix reports 1Q lossMisonix reports 1Q loss
us.rd.yahoo.com - March 13 at 6:22 PM
Misonix reports 2Q lossMisonix reports 2Q loss
us.rd.yahoo.com - March 13 at 6:22 PM
Misonix, Inc. Enters into Exclusive Chinese Distribution Agreement for BoneScalpelMisonix, Inc. Enters into Exclusive Chinese Distribution Agreement for BoneScalpel
us.rd.yahoo.com - March 7 at 10:18 AM
MISONIX INC Files SEC form 10-K, Annual ReportMISONIX INC Files SEC form 10-K, Annual Report
us.rd.yahoo.com - February 9 at 7:42 PM
Misonix Files Form 10-K Announcing Fiscal 2016 Financial ResultsMisonix Files Form 10-K Announcing Fiscal 2016 Financial Results
us.rd.yahoo.com - February 9 at 7:42 PM
Misonix (MSON) Appoints Stavros Vizirgianakis to President and CEOMisonix (MSON) Appoints Stavros Vizirgianakis to President and CEO
www.streetinsider.com - December 20 at 12:35 PM
MISONIX INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsMISONIX INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
biz.yahoo.com - December 19 at 10:04 AM
Misonix Reports Nasdaqs Acceptance of Its Plan to Regain Listing ComplianceMisonix Reports Nasdaq's Acceptance of Its Plan to Regain Listing Compliance
us.rd.yahoo.com - November 30 at 11:30 AM
4:06 pm Misonix announces that Nasdaq accepted its plan to regain compliance and permit the continued listing of Misonix common stock on the Nasdaq Global Market4:06 pm Misonix announces that Nasdaq accepted its plan to regain compliance and permit the continued listing of Misonix common stock on the Nasdaq Global Market
us.rd.yahoo.com - November 30 at 11:30 AM
Misonix (MSON) Plan to Regain Compliance Accepted by NasdaqMisonix (MSON) Plan to Regain Compliance Accepted by Nasdaq
www.streetinsider.com - November 29 at 2:43 PM
MISONIX INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsMISONIX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - November 29 at 2:43 PM
MISONIX INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; TransMISONIX INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Trans
biz.yahoo.com - November 15 at 9:56 AM
DEADLINE ALERT: Brower Piven Notifies...DEADLINE ALERT: Brower Piven Notifies...
www.benzinga.com - November 12 at 8:53 AM
Misonix (MSON) Files to Extend Time on 10-Q Submission; Prelim. Q1 Loss Results Wider Y/YMisonix (MSON) Files to Extend Time on 10-Q Submission; Prelim. Q1 Loss Results Wider Y/Y
www.streetinsider.com - November 11 at 8:47 AM
MISONIX INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsMISONIX INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - November 10 at 9:11 AM
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Misonix, Inc. Investors and Encourages Investors to Contact the FirmGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Misonix, Inc. Investors and Encourages Investors to Contact the Firm
www.businesswire.com - November 1 at 6:35 PM

SEC Filings

Misonix (NASDAQ:MSON) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Misonix (NASDAQ:MSON) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Misonix (NASDAQ MSON) Stock Chart for Saturday, December, 16, 2017

Loading chart…

This page was last updated on 12/16/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.